Free shipping over €200 | Certificate of Analysis included | ✉️ support@certapeptides.com | 💬 Live Chat
Research-grade compound. Laboratory use only. Not intended for human or animal use, ingestion, or injection. No medical claims are made or implied.

Delivers to EU in 7-10 business days
Free shipping over €200 · no customs paperwork (EU) · via EU carrier network
Research-grade Semax + Selank Blend. 99.3% avg purity, HPLC & MS verified. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
MADE TO ORDER — Expected delivery: ~3 weeks
Synthesized after your order is placed. We'll email you tracking details when it ships.
This product is being restocked
We're working with our supplier to restock this item. Sign up below to be the first to know, or save it to your wishlist.
Important Notice
This product is intended for laboratory and research use only. Not for human or veterinary use. By purchasing, you confirm this product will be used exclusively for in-vitro research purposes.
99.3% average HPLC purity, verified by independent third-party testing
Janoshik report published when available
24h dispatch, EU-wide shipping from €4.99
Independent lab verification for every batch
Semax + Selank Blend combines two Russian-developed nootropic peptides with different but complementary mechanisms in a single vial (10mg each, 20mg total). Both were developed by the Institute of Molecular Genetics of the Russian Academy of Sciences and have been used clinically in Russia and Eastern Europe -- an unusual distinction that provides some human pharmacology data, even if the clinical literature predates modern trial standards.
Semax is a synthetic heptapeptide derived from the ACTH(4-7) sequence with a methionine-glutamate-histidine-phenylalanine extension that increases its stability and bioactivity. It acts primarily through BDNF and NGF pathways -- upregulating brain-derived and nerve growth factors. Research effects include neuroprotection, acetylcholinergic and neuropeptidergic receptor binding in memory consolidation models, and attention-related parameters. Semax has been used in Russian clinical practice for ischemic stroke recovery, which provides some translational context, though the evidence base is not equivalent to Western Phase III trial standards.
Selank is derived from tuftsin, an endogenous immunoregulatory peptide, with a GABA-B receptor component that gives it anxiolytic properties. It modulates GABA system activity and reduces anxiety-like behavior in rodent models without the sedation or dependence potential associated with benzodiazepines. Selank also has immunomodulatory properties and has been studied for stress-induced immune suppression in animal models.
The combination addresses both acetylcholinergic and neuropeptidergic receptor binding (Semax) and anxiety/stress modulation (Selank) -- complementary rather than redundant mechanisms in the context of cognitive performance research.
| Parameter | Value |
|---|---|
| Component 1 | Semax 10mg (ACTH(4-7) derivative) |
| Component 2 | Selank 10mg (Tuftsin analogue) |
| Total per Vial | 20mg combined |
| Purity | 99.3% avg HPLC (each component) |
| Format | Lyophilized powder, single-use vial |
| Storage | -20°C before reconstitution; 2-8°C after |
Store at -20°C before reconstitution. Refrigerate at 2-8°C after reconstitution and use within 28 days. Both peptides are stable under proper conditions but should be protected from light and heat.
Semax is derived from the ACTH(4-7) sequence -- the minimal active fragment of adrenocorticotropic hormone -- modified for stability. Its primary documented mechanisms involve upregulation of BDNF and NGF, neurotrophins that support neuronal survival, plasticity, and function. In rodent models it enhances learning, memory consolidation, and attention-related parameters. It also has documented neuroprotective effects in ischemia models, which provided the basis for its clinical use in Russia for stroke recovery.
Selank modulates GABA system activity and has anxiolytic effects in rodent models, but it does not appear to act through the benzodiazepine binding site on GABA-A receptors. Benzodiazepines produce sedation, cognitive impairment, tolerance, and dependence via positive allosteric modulation at GABA-A. Selank's mechanism appears different -- it has GABA-B components and immunomodulatory effects that are not part of benzodiazepine pharmacology. In research models, Selank reduces anxiety-like behavior without the sedation or motor impairment typically associated with classical anxiolytics.
Yes. Both Semax and Selank are commercially available as intranasal sprays in Russia and some Eastern European countries, where they have regulatory approval for specific indications. The intranasal route provides efficient delivery to the CNS via the olfactory pathway, which is particularly relevant for peptides that have limited blood-brain barrier penetration via systemic routes. This product contains the lyophilized peptides for reconstitution in research applications.
Semax + Selank Blend is supplied for laboratory research use only. Not approved for human use. Handle in compliance with institutional biosafety guidelines.
Researcher Confidence
Who actually tests this?
Every batch is independently verified by Janoshik Analytical (100,000+ verifications/month), Eurofins Scientific, and Analytical Sciences International. We publish every Certificate of Analysis.
View COAs →What if I get the wrong batch?
Every bottle label carries a lot number that maps to a specific Certificate of Analysis. If a batch fails spec, we don't ship it — full stop.
View COAs →Where does it ship from?
Romania (EU). We are CERTALAB SRL, CUI RO54451735, VAT-registered. SameDay for Romania, FanCourier for Central/Eastern EU, TCE Worldwide for the rest. 3–7 business days EU-wide.
Shipping details →What if there's a problem?
You have a 14-day withdrawal right under OUG 34/2014 (Romanian/EU consumer law), with ANPC/ODR escalation available. Contact us at support@certapeptides.com.
Returns policy →This product is intended for scientific research and development purposes only. It is a chemical substance that shall not be used as a drug, medicine, active substance, or ingredient in any product intended for human or animal consumption. Researchers must handle this compound in accordance with their institutional biosafety guidelines. Use only in properly equipped laboratory settings with appropriate personal protective equipment.
80mgSAME FIELDResearch-grade Klow Blend (BPC-157 + GHK-Cu + TB-500 + KPV). 99.3% avg purity, HPLC & MS verified. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
18mgSAME FIELDResearch-grade Tesamorelin + Ipamorelin Blend. 99.3% avg purity, HPLC & MS verified. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
10mgSAME FIELDResearch-grade Retatrutide + Cagrilintide Blend. 99.3% avg purity, HPLC & MS verified. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
70mgSAME FIELDThree-peptide co-lyophilized research blend: BPC-157 + GHK-Cu + TB-500 in a single 70mg vial. Targets angiogenesis, cell migration, and extracellular matrix renewal simultaneously. 99.3% avg purity (HPLC verified). COA included. For research purposes only. Not for human consumption.